COCOON Trial Demonstrates Proactive Skincare Reduces Dermatologic Toxicity by 50% in EGFR-Mutant NSCLC Patients
In a groundbreaking development within oncology supportive care, researchers have unveiled compelling interim results from the phase II COCOON trial, ...
